CIK: 0001697228 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $118,084 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PDCC | PEARL DIVER CREDIT COMPANY I | 1,459,021 | $24,074 | 20.4% | $20.01 | — | COM SHS | 70476Q100 |
| NU | NU HLDGS LTD | 1,431,951 | $22,926 | 19.4% | $4.46 | +213.0% | ORD SHS CL A | G6683N103 |
| — | AKERO THERAPEUTICS INC | 328,504 | $15,597 | 13.2% | $30.03 | — | COM | 00973Y108 |
| RNAM | AVIDITY BIOSCIENCES INC | 289,201 | $12,600 | 10.7% | $40.43 | 0.0% | COM | 05370A108 |
| NVDA | NVIDIA CORPORATION | 55,066 | $10,274 | 8.7% | $174.29 | 0.0% | COM | 67066G104 |
| MSFT | MICROSOFT CORP | 19,431 | $10,064 | 8.5% | $508.71 | 0.0% | COM | 594918104 |
| AAPL | APPLE INC | 39,402 | $10,033 | 8.5% | $225.58 | 0.0% | COM | 037833100 |
| DYN | DYNE THERAPEUTICS INC | 517,750 | $6,550 | 5.5% | $11.41 | 0.0% | COM | 26818M108 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 13,007 | $5,966 | 5.1% | $202.89 | +83.9% | COM | 558868105 |